4//SEC Filing
Burke William Patrick 4
Accession 0001645113-22-000001
CIK 0001645113other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:52 PM ET
Size
23.3 KB
Accession
0001645113-22-000001
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Burke William Patrick
Chief Human Resources Officer
Transactions
- Sale
Ordinary Shares
2022-01-03$75.96/sh−2,633$200,003→ 41,036 total - Exercise/Conversion
Ordinary Shares
2022-01-03$7.15/sh+9,750$69,713→ 50,786 total - Sale
Ordinary Shares
2022-01-03$76.09/sh−919$69,924→ 49,867 total - Exercise/Conversion
Ordinary Shares
2022-01-03$21.60/sh+1,402$30,283→ 51,269 total - Sale
Ordinary Shares
2022-01-03$76.03/sh−399$30,336→ 50,870 total - Exercise/Conversion
Options to Buy Ordinary Shares
2022-01-03−17,452→ 0 totalExercise: $11.46Exp: 2026-02-24→ Ordinary Shares (17,452 underlying) - Exercise/Conversion
Options to Buy Ordinary Shares
2022-01-03−9,750→ 0 totalExercise: $7.15Exp: 2027-02-21→ Ordinary Shares (9,750 underlying) - Exercise/Conversion
Options to Buy Ordinary Shares
2022-01-03−1,402→ 6,098 totalExercise: $21.60Exp: 2027-10-30→ Ordinary Shares (1,402 underlying) - Exercise/Conversion
Ordinary Shares
2022-01-03$11.46/sh+17,452$200,000→ 43,669 total
Footnotes (3)
- [F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke.
- [F2]On January 3, 2022, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Burke, Mr. Burke sold 919 shares in multiple trades at prices ranging from $76.00 to $76.09. The price reported above reflects the weighted average sale price. Mr. Burke hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]Fully vested as of the date hereof.
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001880493
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:52 PM ET
- Size
- 23.3 KB